Kristensen Steen Dalby, De Caterina Raffaele, Moliterno David J. (eds.) Therapeutic Strategies in Thrombosis

Clinical Publishing, 2006. — 416 p. — ISBN: 978-1904392347Provides an evidence-based review of therapeutic options currently available for management of thrombosis. Topics include unfractionated heparin, intravenous heparin and low-molecular weight heparin in coronary heart disease, warfarin after acute myocardial infarction, and more. For practitioners.Arterial thrombosis: a brief overview
Aspirin: a risk-based strategy
Clopidogrel and other platelet ADP inhibitors
Glycoprotein IIb/IIIa inhibitors
Unfractionated heparin and low-molecular-weight heparin in coronary heart disease
Intravenous direct thrombin inhibition: acute coronary syndromes and heparin-induced thrombocytopaenia
Direct thrombin inhibition during percutaneous coronary interventions
Pentasaccharide and other factor Xa inhibitors
Direct thrombin inhibition – thromboprophylaxis, deep venous thrombosis, atrial fibrillation and coronary artery disease
Warfarin after acute myocardial infarction
Thrombolytic therapy and concomitant antithrombotic therapy
Pre-hospital reperfusion therapy
Antithrombotic strategies in patients undergoing primary percutaneous intervention
Antithrombotic management in patients with prosthetic valves
Stroke: thrombolysis and antithrombotic therapy
Atrial fibrillation: antithrombotic therapy
Venous thromboembolism: pathophysiology and diagnosis
Antithrombotic therapy in venous thrombosis and pulmonary embolism
Prevention and treatment of venous and arterial thrombosis in patients with specific conditions: diabetes, hypercoagulable states, pregnancy and renal diseases
Monitoring of antithrombotic drugs